The tumorigenic function of the RANKL/RANK signaling pathway was further supported by our findings that blocking this pathway inhibits in vivo steroid hormone (E2 and P4)-dependent LM growth in a xenograft mouse model [11]. The gene discussed is TNFSF11; the disease is lymphangioma.